Development and Use of Human Recombinant <sup>64</sup>Cu-rHCF as a Kidney Glomerulus-Targeted Contrast Agent for Positron Emission Tomography-Reference-Cited by-同舟云学术

Development and Use of Human Recombinant ⁶⁴Cu-rHCF as a Kidney Glomerulus-Targeted Contrast Agent for Positron Emission Tomography

Published:2024-09-06 Issue: Volume: Page:
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

Baldelomar Edwin J.¹²^ORCID,Zhang Hanwen²,Thorek Daniel²^ORCID,Charlton Jennifer R.³,Walker Patrick D.⁴,Wilson Leslie D.⁵,Emoto Kasey C.⁶,Clavijo Jordan Veronica⁷^ORCID,Reichert David E.²^ORCID,Shoghi Kooresh²,Bennett Kevin M.²

Affiliation:

1. XN Biotechnologies, LLC, St. Louis, Missouri 63110, United States

2. Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri 63110, United States

3. Department of Pediatrics, Division of Nephrology, University of Virginia, Charlottesville, Virginia 22904, United States

4. Arkana Laboratories, Little Rock, Arkansas 72211, United States

5. Division of Comparative Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, United States

6. Department of Biology, University of Hawaii at Manoa, Honolulu, Hawai’i 96822, United States

7. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Charlestown, Massachusetts 02115, United States

Funder

National Center for Advancing Translational Sciences

National Institute of Diabetes and Digestive and Kidney Diseases

Office of Research Infrastructure Programs

Eunice Kennedy Shriver National Institute of Child Health and Human Development

LEAP Award - Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship and the Institute for Clinical and Translational Sciences of Washington University in St. Louis

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.4c01027

Reference29 articles.

1. Low birth weight, nephron number, and kidney disease

2. The Clinical Importance of Nephron Mass

3. Nephron Number, Hypertension, Renal Disease, and Renal Failure

4. Renal effects of SGLT2 inhibitors

5. The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus